Next Article in Journal
Sequence Analysis and Comparative Study of the Protein Subunits of Archaeal RNase P
Next Article in Special Issue
Molecular Mechanisms in the Pathogenesis of Alzheimer’s disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation
Previous Article in Journal
Multi-Organ Alcohol-Related Damage: Mechanisms and Treatment
Previous Article in Special Issue
Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
Open AccessReview

New Features about Tau Function and Dysfunction

CIBERNED (Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas), Valderrebollo 5, 28031 Madrid, Spain
CIEN Foundation, Valderrebollo 5, 28041 Madrid, Spain
Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Nicolás cabrera 1, 28049 Madrid, Spain
Author to whom correspondence should be addressed.
Academic Editors: Claude M. Wischik and Charles R. Harrington
Biomolecules 2016, 6(2), 21;
Received: 29 October 2015 / Revised: 9 March 2016 / Accepted: 13 April 2016 / Published: 19 April 2016
(This article belongs to the Special Issue Tau Protein and Alzheimer’s disease)
Tau is a brain microtubule-associated protein that directly binds to a microtubule and dynamically regulates its structure and function. Under pathological conditions, tau self-assembles into filamentous structures that end up forming neurofibrillary tangles. Prominent tau neurofibrillary pathology is a common feature in a number of neurodegenerative disorders, collectively referred to as tauopathies, the most common of which is Alzheimer’s disease (AD). Beyond its classical role as a microtubule-associated protein, recent advances in our understanding of tau cellular functions have revealed novel insights into their important role during pathogenesis and provided potential novel therapeutic targets. Regulation of tau behavior and function under physiological and pathological conditions is mainly achieved through post-translational modifications, including phosphorylation, glycosylation, acetylation, and truncation, among others, indicating the complexity and variability of factors influencing regulation of tau toxicity, all of which have significant implications for the development of novel therapeutic approaches in various neurodegenerative disorders. A more comprehensive understanding of the molecular mechanisms regulating tau function and dysfunction will provide us with a better outline of tau cellular networking and, hopefully, offer new clues for designing more efficient approaches to tackle tauopathies in the near future. View Full-Text
Keywords: Alzheimer’s disease; immunotherapy; neurodegeneration; spreading; tau; tauopathies Alzheimer’s disease; immunotherapy; neurodegeneration; spreading; tau; tauopathies
MDPI and ACS Style

Medina, M.; Hernández, F.; Avila, J. New Features about Tau Function and Dysfunction. Biomolecules 2016, 6, 21.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

Back to TopTop